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Background: Guidelines for the management of adults with hospital-acquired (HAP), ventilator-
associated (VAP), and healthcare-associated (HCAP) pneumonia were recently updated. These 
evidence-based guidelines emphasize early, appropriate antimicrobials, as well as, de-escalation 
of initial therapy based upon microbiologic cultures and clinical response of the patient, and to 
shorten duration of therapy to a minimum effective period.
Objective: To evaluate adherence to the nosocomial pneumonia guidelines before and after 
a multifaceted educational intervention in conjunction with the implementation of an adult 
pneumonia order set.
Methods: A three phase, retrospective, observational analysis was performed among patients 
with nosocomial pneumonia in a tertiary care facility. The phases consisted of an analysis of 
medical charts to identify empiric antimicrobial therapy for patients with nosocomial pneumonia; 
education of physicians on the guidelines; and repeat review of medical charts of patients with 
nosocomial pneumonia to observe for guideline adherence. An adult pneumonia order set was 
introduced to the medical staff prior to the initiation of the observational analysis and provided 
a modality for prescribers to be most compliant with the current recommendations for treating 
pneumonia. Order set utilization was tracked throughout the observational analysis to determine 
if various educational interventions increased compliance.
Results: Thirty-three patients were evaluated pre-education: 5 transferred, 16 discharged, and 
12 died. Thirty-one patients were evaluated post-education: 6 transferred, 21 discharged, and 
4 died. The combined sixty-seven patients received two hundred forty-eight orders for forty-
four unique antimicrobial agents from ﬁ  ve different services. Appropriateness of antimicrobial 
prescribing, designated by adherence to the clinical practice guidelines, did not improve following 
an educational intervention. However, the adult pneumonia order set was utilized in forty-eight 
percent of the post-education group while only being implemented in nine percent of the pre-
education group. The prescribing of single or additional antimicrobials, while utilizing the adult 
pneumonia order set, commonly resulted in overall noncompliance with the consensus guidelines.
Conclusion: This analysis showed that educational efforts alone were not effective in improv-
ing the appropriateness of prescribing empiric antimicrobial therapy in accordance with the 
guidelines. Prescribing compliance with pre-printed orders, in addition to periodic interactive 
educational interventions, should be addressed when introducing and maintaining adherence 
to new clinical practice guidelines.
Keywords: nosocomial pneumonia, clinical practice guidelines, educational intervention, 
pneumonia order set
Background
Hospital-acquired pneumonia (HAP) is deﬁ  ned as pneumonia that occurs at least 
forty-eight hours after hospital admission and the designation of ventilator-associated 
pneumonia (VAP) is given to those patients that develop pneumonia greater than 48–72 
hours after endotracheal intubation. HAP is the second most common nosocomial 
infection in the United States and Europe, and extends total hospital length of stay by Therapeutics and Clinical Risk Management 2007:3(6) 984
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seven to nine days on average (Richards et al 1999; Klavs 
et al 2003; Lizioli et al 2003). Approximately 1% of hospital-
ized patients are affected by HAP and this infectious process 
increases total healthcare costs by more than forty thousand 
dollars. The majority of studies associated with patients 
diagnosed with HAP incorporate critically ill or ventilated 
patients and report a mortality rate of between 30% and 70% 
(Valles et al 2003; Leroy et al 2004). Although, a recent 
multicenter study of non-intensive care patients with HAP 
demonstrated a substantially lower mortality rate at 26% 
(Sopena and Sabria 2005).
Because of the signiﬁ  cant impact of this disease on the 
healthcare system, a joint committee of members of the Infec-
tious Disease Society of America (IDSA) and the American 
Thoracic Society (ATS) published updated guidelines for 
the diagnosis and management of nosocomial pneumonia 
in February 2005 (Niederman and Craven 2005). In these 
guidelines, not only did the committee acknowledge the 
importance of HAP and VAP, but they also introduced a 
new category of pneumonia, healthcare-associated (HCAP). 
HCAP, which is represented by hospitalization for greater 
than 2-days within the past 90-days; residence in a long-
term care facility; recent intravenous antibiotic therapy, 
chemotherapy, or wound care within the past 30-days of 
the current infection; and recent dialysis treatment (clinic or 
hospital); was created due to the recognition that patients in 
this category are at an increased risk of acquiring multi-drug 
resistant (MDR) pathogens. The purpose of developing this 
evidence-based guideline was to ensure a consensus among 
how patients with nosocomial pneumonia are treated, thereby 
optimizing disease state management and antimicrobial 
therapy with the goal of decreasing morbidity and mortality 
associated with this infectious process.
Appropriate antimicrobials, in adequate doses, along with 
the consideration of pharmacodynamic proﬁ  les of the agents 
utilized, is essential to combat the high rate of morbidity and 
mortality associated with HAP (Kollef et al 1999; Hoffken 
and Niederman 2002). Although initial broad-spectrum 
antibiotic coverage is encouraged, it is recommended to dis-
continue unnecessary antimicrobial agents when organisms 
are identiﬁ  ed, in order to minimize the risk of developing 
multi-drug resistant pathogens and patient adverse events 
(Kollef et al 1999; Neiderman and Craven 2005). While the 
guidelines offer many treatment options, the regimens differ 
based upon the time of onset of pneumonia and risk factors 
for MDR pathogens. Therefore, the objectives of this analysis 
was to evaluate adherence with recommended empiric 
antimicrobial selection for patients at risk for MDR pathogen 
associated HAP, VAP, or HCAP before and after educational 
interventions and to determine if the implementation of an 
adult pneumonia order set lead to more improved prescribing 
in accordance with the consensus guidelines.
Methods
This was an Institutional Review Board-approved three 
phase, retrospective, observational analysis conducted over 
9-months at an 881-bed tertiary care facility. The ﬁ  rst three 
months included observation of prescriber adherence to the 
treatment guidelines prior to an education initiative. Next, 
spanning over the course of three months was an educational 
endeavor that consisted of three informal discussions and 
ﬁ  ve formal presentations by local opinion leaders. Audit and 
feedback of recent adherence to clinical practice guidelines 
was performed with forty physicians, who are signiﬁ  cant 
antibiotic prescribers, on two separate occasions. Also, two 
symposiums and one round table discussion were held to 
educate on the most recently updated pneumonia guide-
lines. Each educational activity was well received with the 
most positive feedback received by interacting with opinion 
leaders who clearly outlined the importance of adhering to 
consensus guidelines addressing the treatment of pneumonia. 
There was a combined total of sixty logged hours among the 
authors dedicated to the above listed activities. The majority 
of this time was spent directly educating prescribers on their 
individual prescribing habits and how they may improve in 
order to achieve adherence with current recommendations.
Subsequent to these educational endeavors were three 
months used to evaluate changes in prescribing habits and 
improvement in appropriateness of prescribing antimicro-
bials for the treatment of nosocomial pneumonia. Data 
were obtained from physician progress notes, medication 
administration records, patient ﬂ  ow sheets, computer-based 
laboratory and report systems, and a database of adverse drug 
events. Patients were identiﬁ  ed for observation via review 
of daily laboratory results for positive sputum or bronchoal-
veolar lavage (BAL) cultures. In order to be included in the 
analysis, the following inclusion criteria were applied: ado-
lescent or adult; clinical diagnosis of HAP, VAP, and HCAP; 
chest radiography; physician documentation of pneumonia; 
positive culture results (sputum or BAL). Data collected 
included: gender and age; prescribing physician; speciﬁ  c 
antimicrobials utilized, dose, route, and dosing frequency; 
renal adjustment of antimicrobials performed; sputum and 
BAL culture results; length of intensive care and total hospi-
tal stay; pneumonia onset (5 days or 5 days); discharge 
disposition (discharged, death, or transfer); risk factors for Therapeutics and Clinical Risk Management 2007:3(6) 985
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MDR pathogens causing HAP,VAP, or HCAP; delineation 
of empiric or deﬁ  nitive therapy; antimicrobial(s) prescribed 
at discharge; infectious disease consult obtained. The primary 
point of interest was adherence with recommended empiric 
antimicrobial selection for patients at risk for MDR pathogen 
associated HAP, VAP, or HCAP before and after educational 
interventions. Also evaluated was the utilization of the adult 
pneumonia order set which was introduced before the obser-
vational analysis. It was determined whether patients in the 
analysis were treated per the order set. Data was compiled 
in Microsoft AccessTM and descriptive statistical testing was 
performed using Minitab (Minitab Inc 1998).
Results
Thirty-three patients, with an average length of hospital 
stay of 17.2-days (8.2-days in the ICU), were evaluated pre-
education: 5 transferred, 16 discharged, and 12 died. Thirty-
one patients, with an average length of stay of 15.4-days 
(6.9-days in the ICU), were evaluated post-education: 6 trans-
ferred, 21 discharged, and 4 died. The combined sixty-seven 
patients received two hundred forty-eight orders for forty-four 
unique antimicrobial agents from ﬁ  ve different services. Sub-
optimal empiric therapy was prescribed at approximately the 
same frequency regardless of early or late onset of pneumonia 
(Table 1). Figure 1 illustrates the frequency of pneumonia 
treatment by service. The infectious disease service was 
consulted on only 13% of the study patients. The most com-
mon organisms cultured from sputum or BAL are shown in 
Table 2. The most common reasons for suboptimal adherence 
to the clinical practice guidelines pre- and post-education 
were the use of monotherapy and inadequate Pseudomonas 
aeruginosa and methicillin-resistant Staphylococcus aureus 
(MRSA) coverage. These two multi-drug resistant pathogens 
accounted for the majority of cultured organisms during the 
analysis which is delineated in Table 2. Overall, the percent 
of patients prescribed guideline recommended empiric 
regimens in the post-education phase did not differ from the 
percent receiving recommended empiric regimens in the pre-
education phase. The adult pneumonia order set was better 
received following the educational intervention than before 
considering that it was utilized in forty-eight percent of the 
post-education group while only being implemented in nine 
percent of the pre-education group. However, despite the 
utilization of the order set, prescribers often wrote orders 
for additional antimicrobials leading to decreased guideline 
compliance. The infectious disease service did not use the pre-
printed adult pneumonia orders yet the internal medicine and 
pulmonary services implemented the pre-orders periodically 
on their patients. Compliance with the consensus guidelines 
was well correlated with those services utilizing the order set 
while refraining from ordering only one antimicrobial or an 
alternate, non-recommended, agent.
Discussion
An outcome analysis with this focus provides the opportunity 
to develop a pragmatic approach to addressing prescribing 
habits among patients at risk for or with bacterial infections 
with multi-drug resistant organisms within the healthcare 
organization. This analysis allowed for a two prong approach 
toward improving adherence with clinical practice guidelines. 
First, it served as an educational endeavor with an emphasis 
on educating all healthcare disciplines within the organiza-
tion on the most recently published nosocomial pneumonia 
guidelines, while including an audit and feedback project. 
Secondly, it provided a foundation for the implementation 
of adult pneumonia orders, Figure 2, which can be used to 
guide appropriate prescribing for nosocomial pneumonia. 
Enhanced adherence to clinical practice guidelines for the 
treatment of nosocomial pneumonia will promote a standard 
of practice that limit future trends of bacterial resistance and 
improve patient care and outcomes.
When new clinical practice guidelines are published, it is 
essential to introduce effective strategies to ensure guideline 
adherence. Clinical practice guideline adherence should be 
considered a safety initiative and a quality improvement 
project within healthcare organizations because when used 
inappropriately, or not at all, important healthcare outcomes 
may be compromised (Cook et al 2004). A sole educational 
Table 1 Demographics with pre- and post-education results
     Pre-education    Post-education 
Men, n   23   15 
Women, n   10   16 
Age, mean (range)   58 (11–91)   56 (14–90) 
Onset
  Early, n   14   22 
  Late, n   19   9 
Early-onset appropriate    
therapy    
    Yes, n (%)   2/9 (22%)   4/16 (25%)
    No, n (%)   7/9 (78%)   12/16 (75%)
Late-onset appropriate    
therapy
    Yes, n (%)   4/17 (24%)   1/6 (17%) 
    No, n (%)   13/17 76%)   5/6 (83%) 
Overall appropriateness    
    Yes, n (%)   6/26 (23%)   5/22 (23%) 
    No, n (%)   20/26(77%)   17/22 (77%) Therapeutics and Clinical Risk Management 2007:3(6) 986
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endeavor, serving as the behavior change strategy, has 
been shown to most often be unsuccessful. However, when 
behavior change strategies are approached in a multifaceted 
manner and address documented barriers in the local environ-
ment, their success rate is greatly improved (Thomson et al 
2000; Cook et al 2004). An overview of systemic reviews 
of interventions was published by The Cochrane Effective 
Practice and Organization of Care Review summarizing the 
importance of utilizing multiple implementation strategies 
to translate research ﬁ  ndings into practice (Grimshaw et al 
2001). This summary focused on primary literature that dealt 
with the varying effectiveness of both simple and complex 
behavior change strategies and their effects on clinician 
behavior and patient outcomes (Cabana et al 1999; Grimshaw 
et al 2001). It was determined that preprinted orders and 
periodic interactive educational interventions were most 
beneﬁ  cial when introducing and maintaining behavioral 
change and that mail outs and conferences were the least 
beneﬁ  cial. These literature ﬁ  ndings support the premise that 
it is essential to not only educate yet to also provide a guide 
for prescribers to follow (ie, pre-printed orders) in order to 
improve antimicrobial selection in accordance with the most 
recently published guidelines.
This three phase, retrospective, observational analysis, 
conducted for the purpose of increasing prescriber 
adherence with nosocomial pneumonia clinical practice 
guidelines, would best be deﬁ  ned as a behavior change 
strategy know as the audit and feedback of recent perfor-
mance strategy (Thomson et al 2000). This strategy has 
proven to be insufﬁ  cient as a stand alone modality by which 
to effectively implement quality improvement initiatives. 
However, when coupled with reminders and prompts such 
as pre-printed orders or computer decision support systems, 
it may be considered the backbone for successful initiatives 
(Garg et al 2005). Various adjuncts may be considered to 
aid in behavior change such as formal presentations by 
local opinion leaders and informal or roundtable discussion 
groups. Determining the best behavior change strategies 
Surgery/
Trauma
Pediatrics
Pulmonary Infectious
Disease
Internal
Medicine
Figure 1 Prescribing service.
Table 2 Pathogens cultured from sputum or bronchoalveolar 
lavage
Gram-positive pathogens  Gram-negative pathogens
MRSA 14  P.  aeruginosa  15
S. pneumoniae  6  S. maltophilia  10
MSSA 3  H.  inﬂ  uenzae  5
S. epidermidis  3  K. pneumoniae  4
E. faecium  3  Serratia  4
E. faecalis  2  E. coli  3
S.  pyogenes  1  E. aerogenes  3
Streptococcus 1  E.  cloacae  2
Staphylococcus 1  K.  oxytoca  1
   Enterobacter  1
   C.  koseri  1
   Acinetobacter  1
   P.  mirabilis  1
   B.  cepacia  1Therapeutics and Clinical Risk Management 2007:3(6) 987
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to implement for each project depends not only on the 
effectiveness of the strategy, as published in the literature, 
but also on its past success with previous projects within 
the organization in which it is being implemented. It is 
critical that when embarking upon behavior change strate-
gies, within a healthcare setting, that a multi-disciplinary 
approach be taken. Incorporating the input from the medical 
staff and nursing staff is essential and will help aid in the 
success of guideline adherence. Guidance, direction, and 
support should be solicited from both the Chief Medical 
Ofﬁ  cer and Chief Nursing Ofﬁ  cer for the purpose of solidi-
fying the changes in prescribing habits. This type of support, 
with regard to changing antimicrobial prescribing, is best 
achieved when ﬁ  rst reviewed and recommended directly by 
each of the following committees: Anti-Infective Subcom-
mittee, Pharmacy and Therapeutics Committee, and the 
Medical Executive Committee. Also, various factors such 
as suitability, practicality, and cost must be considered 
when embarking on a quality improvement program that 
will depend on effective and well implemented behavior 
change strategies (Cabana et al 1999; Garg et al 2005).
Conclusion
HAP, VAP, and HCAP are serious pulmonary infectious 
processes associated with signiﬁ  cant morbidity/mortality and 
increased healthcare expenditures and resource consump-
tion. Early and appropriate empiric antimicrobial therapy 
is imperative in order to optimize patient outcomes. This 
analysis showed that educational interventions consisting 
of informal discussions and formal presentations by local 
opinion leaders, audit and feedback of recent adherence to 
clinical practice guidelines, symposiums, and round table 
discussions were only moderately effective in improving the 
appropriateness of prescribing empiric antimicrobial therapy 
in accordance with the guidelines. However, the utilization 
of a broader, multifaceted, pragmatic approach incorporating 
behavioral change strategies that involve absolute adherence 
to pre-printed orders in addition to engaging and site speciﬁ  c 
educational endeavors may serve as the key to success.
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Figure 2 Example of an adult pneumonia order set compliant with clinical practice guidelines.
ADULT PNEUMONIA ORDERS
Meds  
HAP/VAP/HCAP
Pseudomonal risk Polymicrobial
□ Cefepime 2 g IVPB Q 12 H plus □ Piperacillin/Tazobactam 4.5 g IVPB Q 6 H plus
□ Levofloxacin 750 mg IVPB Q 24 H or
□ Tobramycin 7 mg/kg_______mg IVPB X 1
□ Levofloxacin 750 mg IVPB Q 24 H or
□ Tobramycin 7 mg/kg_______mg IVPB X 1
Resistant Gram Positive Infection Suspected:
□ Vancomycin 15 mg/kg______ mg IVPB Q12 H
(desired vancomcyin trough of 15 –20 Mg/mL)
□ Linezolid 600 mg IVPB Q 12 H
Prior to starting any antibiotics below, check to see if first dose was administered in the Emergency
Department and assess renal function for antibiotic dosing appropriateness.
Look for clinical response at day 5 with goal to
discontinue antimicrobials by day 7–8; except for
pseudomonal pneumoniaTherapeutics and Clinical Risk Management 2007:3(6) 988
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no funding, royalties, honoraria, grants, stocks, or other 
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